Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-31 @ 5:54 PM
Study NCT ID:
NCT02901951
Status:
COMPLETED
Last Update Posted:
2020-01-02
First Post:
2016-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-10
First Submit QC Date:
None
Study First Post Date:
2016-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-25
Results First Submit QC Date:
None
Results First Post Date:
2018-08-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-20
Last Update Post Date:
2020-01-02
Last Update Post Date Type:
ACTUAL